A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

NCT00311766 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of patient availability and expiration of study drug

Conditions

Epidermolysis Bullosa

Interventions

DRUG: Thymosin Beta 4
DRUG: Placebo

Sponsor

RegeneRx Biopharmaceuticals, Inc.